Is genetic screening for hemochromatosis worthwhile?NJAJOU, Omer T; ALIZADEH, Behrooz Z; VAN DUIJN, Cornelia M et al.European journal of epidemiology. 2004, Vol 19, Num 2, pp 101-108, issn 0393-2990, 8 p.Article

An insulin-like growth factor-I promoter polymorphism is associated with increased mortality in subjects with myocardial infarction in an elderly caucasian populationYAZDANPANAH, Mojgan; RIETVELD, Ingrid; JANSSEN, Joop A. M. J. L et al.The American journal of cardiology. 2006, Vol 97, Num 9, pp 1274-1276, issn 0002-9149, 3 p.Article

Association between oxidized LDL, obesity and type ₂ diabetes in a population-based cohort, the Health, Aging and Body Composition StudyNJAJOU, Omer T; KANAYA, Alka M; HOLVOET, Paul et al.Diabetes/metabolism research and reviews (Print). 2009, Vol 25, Num 8, pp 733-739, issn 1520-7552, 7 p.Article

The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a dutch populationSUTEDJA, Nadia A; SINKE, Richard J; VAN VUGHT, Paul W. J et al.Archives of neurology (Chicago). 2007, Vol 64, Num 1, pp 63-67, issn 0003-9942, 5 p.Article

HFE gene mutations increase the risk of coronary heart disease in womenPARDO SILVA, M. Carolina; NJAJOU, Omer T; ALIZADEH, Behrooz Z et al.European journal of epidemiology. 2010, Vol 25, Num 9, pp 643-649, issn 0393-2990, 7 p.Article

Does bilirubin protect against hemochromatosis gene (HFE) related mortality?ALIZADEH, Behrooz Z; NJAJOU, Omer T; HOUWING-DUISTERMAAT, Jeanine J et al.American journal of medical genetics. 2004, Vol 129A, Num 1, pp 39-43, issn 0148-7299, 5 p.Article